Trevogrumab Preserves Muscle During Semaglutide Weight Loss
Trevogrumab added to semaglutide cut lean muscle loss in Regeneron's nearly 1,000-patient trial, preserving over 70% of thigh muscle at 52 weeks.
Yutrepia Patent Ruling: Liquidia Plunges After Court Loss
Yutrepia patent ruling: a Delaware court found Liquidia's Yutrepia infringes two valid United Therapeutics patent claims, and Liquidia shares plunged.